National Institute of Pharmaceutical Education and Research Raebareli

The Faculty Development Programme (FDP) on “Medical Devices and AI/ML in Healthcare” successfully concluded at NIPER-Raebareli.

Over the course of the programme, participants gained valuable insights into emerging trends in medical devices, AI/ML applications in healthcare, wearable technologies, diagnostics, and MedTech innovation through expert lectures and interactive sessions by distinguished academicians, clinicians, and industry professionals.

Department of Pharmaceuticals

🎉 Congratulations to 𝗗𝗿. 𝗦𝗮𝗻𝗱𝗲𝗲𝗽 𝗖𝗵𝗮𝘂𝗱𝗵𝗮𝗿𝘆’𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗴𝗿𝗼𝘂𝗽 at NIPER Raebareli on the publication of their research article titled “𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘰𝘧 𝘕𝘰𝘷𝘦𝘭 𝟤-𝘚𝘶𝘣𝘴𝘵𝘪𝘵𝘶𝘵𝘦𝘥-𝟧𝘏-𝘪𝘮𝘪𝘥𝘢𝘻𝘰[𝟤,𝟣-𝘣][𝟣,𝟥]𝘵𝘩𝘪𝘢𝘻𝘪𝘯-𝟧-𝘰𝘯𝘦𝘴 𝘢𝘴 𝘊𝘺𝘵𝘰𝘵𝘰𝘹𝘪𝘤 𝘚𝘺𝘯𝘵𝘩𝘰𝘯𝘴: 𝘎𝘳𝘦𝘦𝘯 𝘚𝘺𝘯𝘵𝘩𝘦𝘴𝘪𝘴, 𝘗𝘩𝘰𝘵𝘰𝘱𝘩𝘺𝘴𝘪𝘤𝘢𝘭 𝘊𝘩𝘢𝘳𝘢𝘤𝘵𝘦𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯, 𝘉𝘪𝘰𝘦𝘷𝘢𝘭𝘶𝘢𝘵𝘪𝘰𝘯, 𝘪𝘯 𝘚𝘪𝘭𝘪𝘤𝘰 𝘢𝘯𝘥 𝘋𝘍𝘛 𝘚𝘵𝘶𝘥𝘪𝘦𝘴” in the prestigious Journal of Molecular Structure (Elsevier).

🎉 Congratulations to Dr. Sandeep Chaudhary’s BHC Research Group at NIPER Raebareli for publishing an invited article in the prestigious journal Current Drug Discovery Technologies!

📘 The article, titled “𝙁𝙪𝙨𝙚𝙙 𝟭𝙃-/𝟮𝙃-𝙄𝙣𝙙𝙖𝙯𝙤𝙡𝙚 𝙖𝙨 𝘽𝙞𝙤𝙖𝙘𝙩𝙞𝙫𝙚 𝙋𝙧𝙞𝙫𝙞𝙡𝙚𝙜𝙚𝙙 𝙎𝙘𝙖𝙛𝙛𝙤𝙡𝙙𝙨: 𝙎𝙮𝙣𝙩𝙝𝙚𝙩𝙞𝙘 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙚𝙨 𝙖𝙣𝙙 𝙋𝙝𝙖𝙧𝙢𝙖𝙘𝙚𝙪𝙩𝙞𝙘𝙖𝙡 𝘼𝙥𝙥𝙡𝙞𝙘𝙖𝙩𝙞𝙤𝙣𝙨”, highlights significant advancements in medicinal chemistry and pharmaceutical research.

𝗗𝗮𝘆 𝟮 of the Faculty Development Programme (FDP) on “Medical Devices & AI/ML in Healthcare” at NIPER Raebareli witnessed engaging technical sessions and insightful discussions.

Congratulations to Dr. Ravinder Kumar Kaundal and his research team on the publication of their research article, “𝗔𝗽𝗶𝗴𝗲𝗻𝗶𝗻 𝗠𝗶𝘁𝗶𝗴𝗮𝘁𝗲𝘀 𝗣𝗙𝗢𝗔-𝗜𝗻𝗱𝘂𝗰𝗲𝗱 𝗔𝗰𝘁𝗶𝘃𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗡𝗟𝗥𝗣𝟯-𝗣𝘆𝗿𝗼𝗽𝘁𝗼𝘀𝗶𝘀 𝗔𝘅𝗶𝘀 𝗮𝗻𝗱 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗗𝗮𝗺𝗮𝗴𝗲” in the prestigious journal Environment & Health (Impact Factor: 6.3).

Congratulations to 𝗔𝘃𝘁𝗮𝗿 𝗦𝗶𝗻𝗴𝗵 𝗚𝗮𝘂𝘁𝗮𝗺, PhD Scholar, on the successful publication of his research work completed under the supervision of 𝗣𝗿𝗼𝗳. 𝗥𝗮𝗸𝗲𝘀𝗵 𝗞𝘂𝗺𝗮𝗿 𝗦𝗶𝗻𝗴𝗵, Head, Pharmacology & Toxicology, at NIPER Raebareli.

Their research article titled:
“𝘊𝘩𝘳𝘺𝘴𝘪𝘯 𝘈𝘮𝘦𝘭𝘪𝘰𝘳𝘢𝘵𝘦𝘥 𝘕𝘦𝘶𝘳𝘰𝘤𝘩𝘦𝘮𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘉𝘦𝘩𝘢𝘷𝘪𝘰𝘶𝘳𝘢𝘭 𝘊𝘩𝘢𝘯𝘨𝘦𝘴 𝘔𝘦𝘥𝘪𝘢𝘵𝘦𝘥 𝘉𝘺 𝘊𝘰𝘮𝘣𝘪𝘯𝘦𝘥 𝘌𝘹𝘱𝘰𝘴𝘶𝘳𝘦 𝘰𝘧 𝘐𝘯𝘵𝘦𝘳𝘭𝘦𝘶𝘬𝘪𝘯-𝟣𝟩𝘈 𝘞𝘪𝘵𝘩 𝘈𝘮𝘺𝘭𝘰𝘪𝘥 𝘉𝘦𝘵𝘢 𝟣–𝟦𝟤 𝘪𝘯 𝘔𝘪𝘤𝘦”has been published in the prestigious 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 𝗼𝗳 𝗡𝗲𝘂𝗿𝗼𝗶𝗺𝗺𝘂𝗻𝗲 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆.

🚀 The Faculty Development Programme (FDP) on “𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘋𝘦𝘷𝘪𝘤𝘦𝘴 & 𝘈𝘐/𝘔𝘓 𝘪𝘯 𝘏𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦” organized by the Department of Medical Devices, NIPER Raebareli, commenced today with great enthusiasm and participation from academicians, researchers, and healthcare innovators.

The programme was inaugurated by Director Prof. Shubhini A. Saraf with the ceremonial lighting of the lamp. Over the next five days, the FDP will focus on emerging areas including Medical Devices, AI/ML applications in healthcare, biosensor diagnostics, wearable technologies, clinical data analytics, and innovation in MedTech.

🎉 Congratulations to the team at the Laboratory of Molecular NeuroTherapeutics (LMNT), NIPER Raebareli, on their latest research publication in the 𝗽𝗿𝗲𝘀𝘁𝗶𝗴𝗶𝗼𝘂𝘀 𝗷𝗼𝘂𝗿𝗻𝗮𝗹 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗡𝗲𝘂𝗿𝗼𝗯𝗶𝗼𝗹𝗼𝗴𝘆 (𝗦𝗽𝗿𝗶𝗻𝗴𝗲𝗿 𝗡𝗮𝘁𝘂𝗿𝗲, 𝗜𝗙: 𝟰.𝟯).

📘 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗧𝗶𝘁𝗹𝗲: “𝘎𝘭𝘺𝘤𝘰𝘨𝘦𝘯 𝘚𝘺𝘯𝘵𝘩𝘢𝘴𝘦 𝘒𝘪𝘯𝘢𝘴𝘦-𝟥β 𝘔𝘦𝘥𝘪𝘢𝘵𝘦𝘴 𝘚𝘶𝘱𝘱𝘳𝘦𝘴𝘴𝘪𝘰𝘯 𝘰𝘧 𝘕𝘦𝘶𝘳𝘪𝘵𝘦 𝘖𝘶𝘵𝘨𝘳𝘰𝘸𝘵𝘩 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘰𝘯𝘪𝘤 𝘏𝘦𝘥𝘨𝘦𝘩𝘰𝘨 𝘚𝘪𝘨𝘯𝘢𝘭𝘭𝘪𝘯𝘨 𝘪𝘯 𝘗𝘢𝘭𝘮𝘪𝘵𝘪𝘤 𝘈𝘤𝘪𝘥-𝘌𝘹𝘱𝘰𝘴𝘦𝘥 𝘕𝘦𝘶𝘳𝘰𝟤𝘈 𝘊𝘦𝘭𝘭𝘴”

Heartiest congratulations to 𝗗𝗿. 𝗥𝗮𝗸𝗲𝘀𝗵 𝗞𝘂𝗺𝗮𝗿 𝗦𝗶𝗻𝗴𝗵, 𝗗𝗿. 𝗦𝗮𝗻𝗱𝗲𝗲𝗽 𝗖𝗵𝗮𝗻𝗱𝗿𝗮𝘀𝗵𝗲𝗸𝗵𝗮𝗿𝗮𝗽𝗽𝗮, and their research team on publishing their research article in the reputed Journal of Molecular Structure (Elsevier).

📘 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗧𝗶𝘁𝗹𝗲: “𝙎𝙮𝙣𝙩𝙝𝙚𝙨𝙞𝙨 𝙖𝙣𝙙 𝙀𝙫𝙖𝙡𝙪𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝘾𝙮𝙘𝙡𝙤𝙥𝙚𝙣𝙩𝙖[𝙚]𝙞𝙣𝙙𝙤𝙡𝙞𝙯𝙞𝙣𝙚 𝘿𝙚𝙧𝙞𝙫𝙖𝙩𝙞𝙫𝙚𝙨 𝙖𝙨 𝙋𝙤𝙩𝙚𝙣𝙩𝙞𝙖𝙡 𝘼𝙣𝙩𝙞-𝙄𝙣𝙛𝙡𝙖𝙢𝙢𝙖𝙩𝙤𝙧𝙮 𝘼𝙜𝙚𝙣𝙩𝙨 𝙏𝙖𝙧𝙜𝙚𝙩𝙞𝙣𝙜 𝙄𝙣𝙛𝙡𝙖𝙢𝙢𝙖𝙩𝙤𝙧𝙮 𝙈𝙚𝙙𝙞𝙖𝙩𝙤𝙧𝙨”

Heartiest congratulations to 𝗗𝗿. Sandeep Chaudhary, Associate Professor at NIPER-Raebareli, on being awarded the 𝗽𝗿𝗲𝘀𝘁𝗶𝗴𝗶𝗼𝘂𝘀 𝗝𝗦𝗣𝗦 𝗕𝗿𝗶𝗱𝗴𝗲 𝗙𝗲𝗹𝗹𝗼𝘄𝘀𝗵𝗶𝗽 𝟮𝟬𝟮𝟲 𝗯𝘆 𝘁𝗵𝗲 𝗝𝗮𝗽𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗣𝗿𝗼𝗺𝗼𝘁𝗶𝗼𝗻 𝗼𝗳 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 for the year 2026–27.

This fully funded 30-day fellowship will further 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗰 𝗻𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗜𝗻𝗱𝗶𝗮 𝗮𝗻𝗱 𝗝𝗮𝗽𝗮𝗻, fostering international scientific partnerships and innovation.

NIPER Raebareli takes immense pride in this remarkable achievement and extends best wishes to 𝗗𝗿. 𝗖𝗵𝗮𝘂𝗱𝗵𝗮𝗿𝘆 for his continued success in advancing global research excellence.

Congratulations to the research groups of Dr. Sandeep Chandrashekharappa and Dr. Ravinder Kaundal on the publication of their research article, “Ellagitannin-derived metabolite Urolithin A suppresses NCOA4-dependent ferritinophagy and attenuates ferroptosis following cerebral ischemia reperfusion injury,” in Food Bioscience (Impact Factor: 5.9).